MGRX
HEALTHCAREMangoceuticals Inc
$0.35+0.03 (+9.76%)PRE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving MGRX Today?
No stock-specific AI insight has been generated for MGRX yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$0.16$2.75
$0.35
Fundamentals
Market Cap$6M
P/E Ratio—
EPS$-2.17
Dividend Yield—
Dividend / Share—
ROE-1.4%
Profit Margin—
Debt / Equity—
Trading
Volume1.1M
Avg Volume (10D)—
Shares Outstanding17.0M
MGRX News
13 articles- BC-Most Active StocksYahoo Finance·Mar 23, 2026
- Mangoceuticals Announces Lawsuit Seeking Damages Exceeding $73 Million Against Former Technology Consulting and Software Development Firm, Clarity Ventures, Inc.Yahoo Finance·Mar 17, 2026
- Mangoceuticals, Inc. Announces PCT Patent Filing for MGX-0024 Antiviral Technology to Include Inhibiting Respiratory or Orally Acquired Virus Infection in Animals or BirdsYahoo Finance·Mar 6, 2026
- Mangoceuticals’ Patented MGX-0024 Achieves Zero Respiratory-Related Mortality in 29,000-Bird Field Trials and Demonstrates Prophylactic Benefit Against H5N1 in Controlled Government StudyYahoo Finance·Feb 23, 2026
- MangoRx Experiences Initial Success with Newly Launched $99/month All-Inclusive Injectable Testosterone Replacement Therapy (TRT) Treatment ProgramYahoo Finance·Feb 19, 2026
- Top Midday DeclinersYahoo Finance·Dec 19, 2025
- Mangoceuticals, Inc. Announces Closing of $2.5 Million Registered Direct and Private PlacementsYahoo Finance·Dec 19, 2025
- Mangoceuticals, Inc. Announces $2.5 Million Registered Direct and Private Placements Priced at the Market Under Nasdaq RulesYahoo Finance·Dec 18, 2025
- Eli Lilly and Novo Nordisk disown Mangoceuticals’ GLP-1RA partnership claimPharmaceutical-technology·Nov 14, 2025
- Mangoceuticals Provides Clarification on Launch of Branded GLP-1 Weight-Management ProgramsYahoo Finance·Nov 14, 2025
- Mangoceuticals Partners with Eli Lilly and Novo Nordisk to Deliver Affordable Access to Zepbound and Wegovy for Obesity ManagementYahoo Finance·Nov 13, 2025
- Mangoceuticals shares results from field studies on MGX-0024Yahoo Finance·May 28, 2025
- Mangoceuticals’ Patented MGX-0024 Delivers 100% Respiratory Survival in Poultry Studies Signaling Strong Potential Defense Against Spread of Avian FluYahoo Finance·May 27, 2025
All 13 articles loaded
Price Data
Open$0.31
Previous Close$0.32
Day High$0.39
Day Low$0.31
52 Week High$2.75
52 Week Low$0.16
52-Week Range
$0.16$2.75
$0.35
Fundamentals
Market Cap$6M
P/E Ratio—
EPS$-2.17
Dividend Yield—
Dividend / Share—
ROE-1.4%
Profit Margin—
Debt / Equity—
Trading
Volume1.1M
Avg Volume (10D)—
Shares Outstanding17.0M
About Mangoceuticals Inc
Mangoceuticals, Inc. focuses to develop, market, and sell various men's wellness products and services through a telemedicine platform. The company is headquartered in Dallas, Texas.
Listed March 21, 2023
HEALTHCAREHEALTH INFORMATION SERVICES
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICHEALTH INFORMATION SERVICES
CIK—
Composite FIGI—
Share Class FIGI—